You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Design, Development and Therapy: First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers - http://doi.org/10.2147/DDDT.S235802 #8
August 2020 Drug Design, Development and Therapy Volume 14:3189-3199
DOI: 10.2147/DDDT.S235802